Mycoplasma pneumoniae reinfection and vaccination: Protective oral vaccination and harmful immunoreactivity after re-infection and parenteral immunization

Vaccine

Volumn 14, Issue 15, 1996, Pages 1479-1483

  Cimolai, Nevio ^a   Cheong, Anne C H ^a   Morrison, Brenda J ^b   Taylor, Glenn P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

Mycoplasma pneumoniae; Pneumonia; Vaccine

Indexed keywords

BACTERIAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HAMSTER; IMMUNOGENICITY; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CRICETINAE; HORSES; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; LUNG; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; VACCINATION; VACCINES, INACTIVATED;

EID: 0030448128     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00068-0     Document Type: Article

References (26)

1. 1 Hayatsu, E. Acquired immunity to Mycoplasma pneumoniae in hamsters. Microbiol. Immun. 1978, 22, 181-195
2. 2 Hayatsu, E., Kawakubo, Y., Yayoshi, M., Araake, M., Yoshioka, M. and Nishiyama, Y. Role of humoral antibodies in resistance to Mycoplasma pneumoniae pneumonia in hamsters. Microbiol. Immun. 1980, 24, 585-593
3. 3 Hayatsu, E., Kawakubo, Y., Yayoshi, M. et al. Immunological responses of hamsters in the acquired immune state to Mycoplasma pneumoniae infection. Microbiol. Immun. 1981, 25, 1255-1263
4. 4 Katsura, T., Kanamori, M., Kitamoto, O. and Ogata, S. Protective effect of colostrum in Mycoplasma pneumoniae infection induced in infant mice. Microbiol. Immun. 1985, 29, 883-894
5. 5 Barile, M.F., Chandler, D.K.F., Yoshida, H., Grabowski, M.W. and Razin, S. Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Infect. Immun. 1988, 56, 2450-2457
6. 6 Weibel, R.E., Stokes, J., Mascoli, C.C. et al. Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1,2,3 and Mycoplasma pneumoniae vaccines, 1965-1966. Am. Rev. Resp. Dis. 1967, 96, 724-739
7. 7 Mogabgab, W.J. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel, 1964-1966. Am. Rev. Resp. Dis. 1968, 97, 359-365
8. 8 Mogabgab, W.J. Efficacy of inactivated Mycoplasma pneumoniae vaccine demonstrated by protection in large field trials. Ann. NY. Acad. Sci. 1973, 225, 453-461
9. 9 Fernald, G.W. and Clyde, W.A. Protective effect of vaccines in experimental Mycoplasma pneumoniae disease. Infect. Immun. 1970, 1, 559-565
10. 10 Jacobs, E., Stuhlert, A., Drews, M. et al. Host reactions to Mycoplasma pneumoniae infections in guinea pigs pre-immunized systematically with the adhesin of this pathogen. Microbiol. Pathogen. 1988, 5, 259-265
11. 11 Cimolai, N., Taylor, G.P., Mah, D. and Morrison, B.J. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immun. 1992, 36, 465-478
12. 12 Cimolai, N., Mah, D.G., Taylor, G.P. and Morrison, B.J. Bases for the early immune response after rechallenge or component vaccination in an animal model of acute Mycoplasma pneumoniae pneumonitis. Vaccine 1995, 13, 305-309
13. 13 Clyde, W.A. Immunopathology of experimental Mycoplasma pneumoniae disease. Infect. Immun. 1971, 4, 757-763
14. 14 Fernald, G.W., Clyde, W.A. and Bienenstock, J. Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J. Immun. 1972, 108, 1400-1408
15. 15 Cimolai, N., Bryan, L.E., To, M. and Woods, D.E. Immunological crossreactivity of a Mycoplasma pneumoniae membrane-associated protein antigen with Mycoplsma genitalium and Acholeplasma laidlawii. J. Clin. Microbiol. 1987, 25, 2136-2139
16. 16 Taylor-Robinson, D., Purcell, R.H., Wong, D.C. and Chanock, R.M. A color test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J. Hygiene 1966, 64, 91-104
17. 17 Cimolai, N., Mah, D., Thomas, E. and Middleton, P. Rapid immunoblot diagnosis of acute Mycoplasma pneumoniae infection. Eur. J. Clin. Micro. Inf. Dis. 1990, 9, 223-236
18. 18 Cimolai, N. and Cheong, A.C.H. IgM anti-P1 immunoblotting: a standard for the rapid serological diagnosis of Mycoplasma pneumoniae infection in pediatric care. Chest 1992, 102, 477-481
19. 19 Rollins, S., Colby, T. and Clayton, F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch. Pathol. Lab. Med. 1986, 110, 34-41
20. 20 Jensen, K.E., Senterfit, L.B., Chanock, R.M., Smith, C.B. and Purcell, R.H. An inactivated Mycoplasma pneumoniae vaccine. J. Am. Med. Assoc. 1965, 194, 134-138
21. 21 Barile, M.F., Grabowski, M.W., Kapatais-Zoumbois, K., Brown, B., Hu, P.-C. and Chandler, D.K.F. Protection of immunized and previously infected chimpanzees challenged with Mycoplasma pneumoniae. Vaccine 1994, 12, 707-714
22. 22 Smith, C.B., Friedewald, W.T. and Chanock, R.M. Inactivated Mycoplasma pneumoniae vaccine: evaluation in volunteers. J. Am. Med. Assoc. 1967, 199, 353-358
23. 23 Vu, A.C., Foy, H.M., Cartwright, F.D. and Kenny, G.E. The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period. Infect. Immun. 1978, 55, 1830-1836
24. 24 Stevens, M.K. and Krause, D.C. Mycoplasma pneumoniae cytadherance phase-variable protein HMW3 is a component of the attachment organelle. J. Bacteriol. 1992, 174, 4265-4275
25. 25 McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Herasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
26. 26 Czinn, S.J., Cai, A. and Nedrud, J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993, 11, 637-642